Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effectiveness and cost-effectiveness of eliminating cervical cancer through a tailored optimal pathway: a modeling study
Changfa Xia, Xiaoqian Xu, Xuelian Zhao, et al.
BMC Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Cancer statistics in China and United States, 2022: profiles, trends, and determinants
Changfa Xia, Xuesi Dong, Li He, et al.
Chinese Medical Journal (2022) Vol. 135, Iss. 5, pp. 584-590
Open Access | Times Cited: 2555
Strategies to eliminate cervical cancer in China
Lü Ji, Manli Chen, Lan Yao
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 22
Opportunities and challenges for human papillomavirus vaccination in China
Chao Zhao, Yun Zhao, Jingran Li, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 14
Head-to-head immunogenicity comparison of an Escherichia coli-produced 9-valent human papillomavirus vaccine and Gardasil 9 in women aged 18–26 years in China: a randomised blinded clinical trial
Fengcai Zhu, Guohua Zhong, Weijin Huang, et al.
The Lancet Infectious Diseases (2023) Vol. 23, Iss. 11, pp. 1313-1322
Closed Access | Times Cited: 17
Health and economic impact of delaying large-scale HPV vaccination and screening implementation on cervical cancer in China: a modelling study
Meng Gao, Shangying Hu, Xuelian Zhao, et al.
The Lancet Regional Health - Western Pacific (2023) Vol. 36, pp. 100768-100768
Open Access | Times Cited: 15
How can China achieve WHO’s 2030 targets for eliminating cervical cancer?
Fanghui Zhao, Jinghe Lang, You‐Lin Qiao, et al.
BMJ (2024), pp. e078641-e078641
Open Access | Times Cited: 4
Tumor Microenvironment Targeted by Polysaccharides in Cancer Prevention: Expanding Roles of Gut Microbiota and Metabolites
Shuai Han, Yixin Luo, Zuomin Hu, et al.
Molecular Nutrition & Food Research (2025)
Closed Access
Cervical cancer screening by cotesting method for Vietnamese women 25–55 years old: a cost-effectiveness analysis
Hien Bui, Van Nu Hanh Pham, Thang Hong Vu
BMJ Open (2025) Vol. 15, Iss. 1, pp. e082145-e082145
Open Access
Cost-effectiveness analysis of switching from a bivalent to a nonavalent HPV vaccination programme in China: a modelling study
Meng Gao, Shangying Hu, Xuelian Zhao, et al.
The Lancet Regional Health - Western Pacific (2025) Vol. 56, pp. 101499-101499
Open Access
ZNF671 methylation test in cervical scrapings for cervical intraepithelial neoplasia grade 3 and cervical cancer detection
Peng Zhu, Jing Xiong, Ding Yuan, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 8, pp. 101143-101143
Open Access | Times Cited: 12
HPV prevalence and genotype distribution among women in eastern China during the Covid-19 pandemic
Yongmei Ma, Xiyan Xia, Wen Zheng, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 1
Open Access | Times Cited: 9
Projected Time for the Elimination of Cervical Cancer Under Various Intervention Scenarios: Age-Period-Cohort Macrosimulation Study
Yi‐Chu Chen, Yun‐Yuan Chen, Shih‐Yung Su, et al.
JMIR Public Health and Surveillance (2024) Vol. 10, pp. e46360-e46360
Open Access | Times Cited: 3
Strategies to accelerate the elimination of cervical cancer in British Columbia, Canada: a modelling study
Reka Pataky, Sara Izadi‐Najafabadi, Laurie Smith, et al.
Canadian Medical Association Journal (2024) Vol. 196, Iss. 21, pp. E716-E723
Open Access | Times Cited: 3
Dynamics of SARS-CoV-2 mutations reveals regional-specificity and similar trends of N501 and high-frequency mutation N501Y in different levels of control measures
Santiago Justo Arévalo, Daniela Zapata Sifuentes, César J. Huallpa, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 19
A comparison of behavioural models explaining cervical cancer screening uptake
Jyoshma Preema Dsouza, Stephan Van den Broucke, Sanjay Pattanshetty, et al.
BMC Women s Health (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 13
Optimal allocation strategies for HPV vaccination introduction and expansion in China accommodated to different supply and dose schedule scenarios: a modelling study
Tingting You, Xuelian Zhao, Shangying Hu, et al.
EClinicalMedicine (2022) Vol. 56, pp. 101789-101789
Open Access | Times Cited: 12
Cost-effectiveness of the screen-and-treat strategies using HPV test linked to thermal ablation for cervical cancer prevention in China: a modeling study
Xuelian Zhao, Shuang Zhao, Changfa Xia, et al.
BMC Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 7
Informing HPV vaccine pricing for government-funded vaccination in mainland China: a modelling study
Tingting You, Xuelian Zhao, Chenghao Pan, et al.
The Lancet Regional Health - Western Pacific (2024) Vol. 52, pp. 101209-101209
Open Access | Times Cited: 2
Immunogenicity and safety of two novel human papillomavirus 4- and 9-valent vaccines in Chinese women aged 20–45 years: A randomized, blinded, controlled with Gardasil (type 6/11/16/18), phase III non-inferiority clinical trial
Yajun Shu, Yebin Yu, Ying Ji, et al.
Vaccine (2022) Vol. 40, Iss. 48, pp. 6947-6955
Open Access | Times Cited: 12
Analysis of the disease burden trend of malignant tumors of the female reproductive system in China from 2006 to 2020
Xiting Han, Zhihong Wang, Dongmei Huang, et al.
BMC Women s Health (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 12
The road to cervical cancer elimination in Malaysia: Evaluation of the impact and cost‐effectiveness of human papillomavirus screening with self‐collection and digital registry support
Adam Keane, Chiu‐Wan Ng, Kate T. Simms, et al.
International Journal of Cancer (2021) Vol. 149, Iss. 12, pp. 1997-2009
Open Access | Times Cited: 15
Willingness to pay for HPV vaccine among female health care workers in a Chinese nationwide survey
Xinyue Lu, Mengdi Ji, Abram L. Wagner, et al.
BMC Health Services Research (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 10
Comparison of multiplex PCR capillary electrophoresis assay and PCR-reverse dot blot assay for human papillomavirus DNA genotyping detection in cervical cancer tissue specimens
Lei Qin, Dan Li, Zhihui Wang, et al.
Frontiers in Public Health (2024) Vol. 12
Open Access | Times Cited: 1
Modeling the Health Impact and Cost-Effectiveness of a Combined Schoolgirl HPV Vaccination and Cervical Cancer Screening Program in Guangdong Province, China
Yating Huang, Dantao Zhang, Lihua Yin, et al.
Children (2024) Vol. 11, Iss. 1, pp. 103-103
Open Access | Times Cited: 1
Equitable expansion of preventive health to address the disease and economic effect of ageing demographics
Mitin Nachu, Edward Christopher Dee, Nishwant Swami
The Lancet Healthy Longevity (2023) Vol. 4, Iss. 4, pp. e131-e131
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top